Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels (GEMINI-AALA)
Not Applicable
- Registration Number
- PER-010-04
- Lead Sponsor
- PFIZER S.A.,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinical diagnosis of high blood pressure and low density lipoprotein cholesterol levels, which require medication.
Exclusion Criteria
Patients with blood pressure maintained adequately to the target with or without medication
Patients currently receiving treatment with amlodipine and atorvastatin or who are not at blood pressure or lipid level while taking the highest dose of amlodipine or atorvastatin, respectively
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br>Outcome name:Levels of blood pressure and lipids.<br>Measure:The therapeutic efficacy of amlodipine / atorvastatin by evaluation of the percentage of subjects trying to treat, who achieve the goals of treatment of both blood pressure and lipids<br>Timepoints:14 day<br>
- Secondary Outcome Measures
Name Time Method <br>Outcome name:summary of serious adverse events (EASs) or other available safety information including all serious unexpected adverse events related to the drug<br>Measure:To assess the safety of dual therapy with titration of the doses of amlodipine and atorvastatin to achieve therapeutic goals in TA and LDL-C.<br>Timepoints:throughout the study<br>